DOJ Escalates Its War On Health Care Fraud: Glaxosmithkline Agrees To Pay Record-Setting $3 Billion To Settle U.S. Investigations.
Mondaq Business Briefing › Nbr. 2011, January 2011
Linked as:
Extract
DOJ Escalates Its War On Health Care Fraud: Glaxosmithkline Agrees To Pay Record-Setting $3 Billion To Settle U.S. Investigations.
British pharmaceutical company GlaxoSmithKline (GSK) announced on November 3, 2011, that it had reached an agreement in principle with the United States government to resolve multiple federal investigations regarding the...
See the full content of this document
Sponsored links
